about
Phosphodiesterase-4 inhibition alters gene expression and improves isoniazid-mediated clearance of Mycobacterium tuberculosis in rabbit lungsA new recombinant bacille Calmette-Guérin vaccine safely induces significantly enhanced tuberculosis-specific immunity in human volunteersTranslational Research for Tuberculosis Elimination: Priorities, Challenges, and ActionsExperimental tuberculosis in the Wistar rat: a model for protective immunity and control of infectionPhosphodiesterase-4 inhibition combined with isoniazid treatment of rabbits with pulmonary tuberculosis reduces macrophage activation and lung pathologyPhosphodiesterase 4 inhibition reduces innate immunity and improves isoniazid clearance of Mycobacterium tuberculosis in the lungs of infected miceThe role of RelMtb-mediated adaptation to stationary phase in long-term persistence of Mycobacterium tuberculosis in miceFunction and regulation of class I ribonucleotide reductase-encoding genes in mycobacteriaThe role of MmpL8 in sulfatide biogenesis and virulence of Mycobacterium tuberculosisA subset of circulating blood mycobacteria-specific CD4 T cells can predict the time to Mycobacterium tuberculosis sputum culture conversionEffect of standard tuberculosis treatment on plasma cytokine levels in patients with active pulmonary tuberculosisMacrophage migration inhibitory factor (MIF) is a critical mediator of the innate immune response to Mycobacterium tuberculosis.Genetic variation in TLR genes in Ugandan and South African populations and comparison with HapMap dataHuman TLR1 deficiency is associated with impaired mycobacterial signaling and protection from leprosy reversal reaction.Adjunctive thalidomide therapy for childhood tuberculous meningitis: results of a randomized study.Transcriptional profiling of mycobacterial antigen-induced responses in infants vaccinated with BCG at birthMycobacterium leprae actively modulates the cytokine response in naive human monocytes.A combination of baseline plasma immune markers can predict therapeutic response in multidrug resistant tuberculosis.HIV-1 infection in infants severely impairs the immune response induced by Bacille Calmette-Guérin vaccine.Induction of ER stress in macrophages of tuberculosis granulomas.Differential expression of iron-, carbon-, and oxygen-responsive mycobacterial genes in the lungs of chronically infected mice and tuberculosis patients.Innate immune response to Mycobacterium tuberculosis Beijing and other genotypes.Role of the DinB homologs Rv1537 and Rv3056 in Mycobacterium tuberculosisCommon polymorphisms in the NOD2 gene region are associated with leprosy and its reactive states.Association of human TLR1 and TLR6 deficiency with altered immune responses to BCG vaccination in South African infants.Factors affecting tuberculosis strain success over 10 years in a high TB- and HIV-burdened community.Caseation of human tuberculosis granulomas correlates with elevated host lipid metabolism.Antibody profiles characteristic of Mycobacterium tuberculosis infection state.BCG induces protection against Mycobacterium tuberculosis infection in the Wistar rat model.Molecular epidemiology of Mycobacterium tuberculosis in a South African community with high HIV prevalence.Use of IMiD3, a thalidomide analog, as an adjunct to therapy for experimental tuberculous meningitis.Etanercept exacerbates inflammation and pathology in a rabbit model of active pulmonary tuberculosisMycobacterial antigens exacerbate disease manifestations in Mycobacterium tuberculosis-infected mice.Association of TNF, MBL, and VDR polymorphisms with leprosy phenotypes.Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy.Antiretroviral program associated with reduction in untreated prevalent tuberculosis in a South African township.Induction of granulysin and perforin cytolytic mediator expression in 10-week-old infants vaccinated with BCG at birth.Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens.Toll-like receptor 2 (TLR2) polymorphisms are associated with reversal reaction in leprosyMycobacterium tuberculosis growth at the cavity surface: a microenvironment with failed immunity
P50
Q21089606-50E489D6-2560-49F2-8A29-3B89E93F4745Q24657992-ED39FD37-9B97-41CD-8FC2-2C48D494072AQ26765051-7CB6F6AF-0947-4A7F-8E20-68B4D9A9E96DQ27347857-715E34C3-A8C1-49CF-B5A5-920D1FEF487BQ28389823-A7036499-3098-4421-9799-C6C442ADEA6AQ28477281-CB6A0D17-B2CA-4076-B5F5-5186CF3EB4CDQ28486838-D844EAAC-BF38-4F2A-BAD1-0A22028CEEFFQ28486854-904697B5-78E1-4902-ACCE-6D268642548EQ28487367-F080148F-15A3-436C-847E-0F7AF378E12EQ28541001-4AF0B1C3-7DBB-451A-B751-5245C9516868Q28729980-90293666-CD0E-4354-AFE7-839D8D3FF998Q30414897-B6EBE868-780B-4A25-980A-0A5499007ED4Q30575475-9074FB04-49EE-4888-9A4A-747F4BAC4693Q33332129-8313A255-534F-404B-9122-51FCFB24F93AQ33360969-F0BBB123-1B3A-4E3C-8572-40D77016FC71Q33411968-FE19AAA9-8006-4E9E-961A-E9ABDEF4F584Q33557846-0B27F7F3-FE7D-4AC4-B1B3-1CA8DBAB97ABQ33626683-6765C902-44BD-4A36-8BD9-908AB44A9B78Q33627000-03519D28-D3AE-434F-A929-BBDAB62C53BBQ33697646-A341C2B2-9DBE-4D7C-98F5-0B8BD59B5551Q33716960-40B7BBC7-7237-4E2D-AE15-D6B33BE01A54Q33737727-569D2D49-1F7B-4901-8973-95C793831983Q33769195-C2E06F14-6373-4329-ABD4-0CABB34C74FDQ33785762-9A390506-0A4A-43FB-88FF-054B3DD24B41Q33996621-F73AEED3-7611-4DAF-99C2-A5EEF6E70A81Q34001209-0FCA4117-75CC-4571-9942-91BFF8D9A752Q34033091-B2B59ED8-7E99-40B5-9C79-6B5A05684B17Q34033405-E99A2A60-84F3-42B9-9BF7-C215499B0B80Q34097601-44FF8C0B-9E52-4C43-BD41-7BB8E6BBD9DAQ34100685-AFB9706D-E55C-497B-9AC8-4411BC667023Q34109469-4358F2FD-D840-48B2-AA11-0CC2C3046C47Q34113978-71E4C438-50AF-4244-BB33-D0758A092C6CQ34120690-BDF29DC9-7E6F-4938-BB05-29ACE5A09723Q34137717-7B7A683D-3056-496A-A570-1200D39CAD1DQ34181985-DAE44D8E-260F-4339-8CF6-DD290B1BBC36Q34268952-8E5AF539-7E04-4DB4-8F71-5BBAB2CE329DQ34479089-CB6FD849-4B5E-4485-BD12-9B9C92A72A0BQ34657537-8C4EDCF4-629A-47BA-8C73-86FCC84F3045Q34797664-26B435A0-0107-4ABB-8D62-F44D534E87AFQ34945420-A4325540-7A89-4C63-8314-00D74E249E0A
P50
description
physician
@en
name
Gilla Kaplan
@ast
Gilla Kaplan
@en
Gilla Kaplan
@es
Gilla Kaplan
@nl
type
label
Gilla Kaplan
@ast
Gilla Kaplan
@en
Gilla Kaplan
@es
Gilla Kaplan
@nl
altLabel
G Kaplan
@en
G. Kaplan
@en
Kaplan G
@en
Kaplan G.
@en
Kaplan
@en
prefLabel
Gilla Kaplan
@ast
Gilla Kaplan
@en
Gilla Kaplan
@es
Gilla Kaplan
@nl
P1960
X2pcBo4AAAAJ